Ophthalmology Therapeutics Market

26.09.2018 Views

RESEARCH REPORT SEP - 2018 OPHTHALMOLOGY THERAPEUTICS MARKET SEGMENTED BY PRODUCTS, BY CONSUMBLES, AND BY APPLICATION, SIZE, SHARE, GROWTH, TRENDS AND FORECASTS 2018-2023

RESEARCH REPORT<br />

SEP - 2018<br />

OPHTHALMOLOGY THERAPEUTICS MARKET<br />

SEGMENTED BY PRODUCTS, BY CONSUMBLES, AND BY APPLICATION, SIZE,<br />

SHARE, GROWTH, TRENDS AND FORECASTS 2018-2023


<strong>Ophthalmology</strong> therapeutics <strong>Market</strong><br />

Europe <strong>Ophthalmology</strong> <strong>Therapeutics</strong> <strong>Market</strong> was worth $6.44 billion in 2018 and<br />

estimated to be growing at a CAGR of 6.9%, to reach $8.98 billion by 2023. The<br />

market is showing evident potential in the mentioned forecast period. <strong>Ophthalmology</strong><br />

deals with the treatment of eye defects and diseases. Age related macular degeneration<br />

is the major cause of visual loss in adults in industrialised countries, other conditions<br />

associated with vision loss include cataract, diabetic retinopathy, and glaucoma along<br />

with low vision.<br />

There are around 25 million people with visual impairment in the Europe. It is estimated<br />

that more than 70 million people have eye diseases that are in the early stages which if<br />

left untreated may lead to severe impairment.<br />

Europe <strong>Ophthalmology</strong> <strong>Therapeutics</strong> is driven by the increasing incidence of vision<br />

impairment. Advancements in technology in the field of medicine are also playing a key<br />

role in the growth of the market. Growing geriatric population across the continent along<br />

with an increase in disposable income of the people are some of the factors adding up to<br />

the market growth. However, Stringent regulatory framework and unclear reimbursement<br />

policies are also acting as hurdles for market growth. Lack of awareness about various<br />

diseases associated with ophthalmology is also a major restraint hindering the market<br />

growth.<br />

Europe <strong>Market</strong> for <strong>Ophthalmology</strong> <strong>Therapeutics</strong> is broadly segmented into Indication<br />

and End User. On the basis of indication, the market is analysed as Glaucoma, Dry Eye<br />

Syndrome, Diabetic Retinopathy, Retinal Vein Occlusion, Age-related Macular<br />

Degeneration, Macular Edema and Allergic Conjunctivitis. Glaucoma is the largest<br />

indication segment accounting for a share of approximately 31% followed by AMD with a<br />

share of XX%. Based on End User the market is segmented into Hospitals, Eye Clinics,<br />

Diagnostic Centres and Patients. Geographically, Europe <strong>Ophthalmology</strong> <strong>Therapeutics</strong><br />

market is segmented into United Kingdom, Germany, France, Italy and Spain. Within<br />

Europe, Germany is the largest market for <strong>Ophthalmology</strong> <strong>Therapeutics</strong><br />

Some of the major companies covered in the report are Pfizer Inc., Allergan Inc., Alcon<br />

Inc., Merck & co. Inc., Roche Valeant, Regeneron, Santen, Bayer, Senju, Lpath and Eye<br />

Gate Pharmaceuticals<br />

TABLE OF CONTE<br />

1. Introduction<br />

1.1 <strong>Market</strong> Definition<br />

1.2 Study Deliverables<br />

1.3 Base Currency, Base Year and Forecast Periods<br />

1.4 General Study Assumptions<br />

2. Research Methodology<br />

2.1 Introduction<br />

+1 888-702-9626 | www.marketdataforecast.com | contact@marketdataforecast.com


<strong>Ophthalmology</strong> therapeutics <strong>Market</strong><br />

2.2 Research Phases<br />

2.2.1 Secondary Research<br />

2.2.2 Primary Research<br />

2.2.3 Econometric Modelling<br />

2.2.4 Expert Validation<br />

2.3 Analysis Design<br />

2.4 Study Timeline<br />

3. Overview<br />

3.1 Executive Summary<br />

3.2 Key Inferences<br />

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)<br />

4.1 <strong>Market</strong> Drivers<br />

4.2 <strong>Market</strong> Restraints<br />

4.3 Key Challenges<br />

4.4 Current Opportunities in the <strong>Market</strong><br />

Request Report Sample: https://www.marketdataforecast.com/market-reports/europeophthalmology-therapeutics-market-1108/request-sample<br />

5. <strong>Market</strong> Segmentation<br />

5.1 By Indication<br />

5.1.1 Glaucoma<br />

5.1.2 Dry Eye Syndrome<br />

5.1.3 Diabetic Retinopathy<br />

5.1.4 Retinal Vein Occlusion<br />

5.1.5 Age-Related Macular Degeneration (AMD)<br />

5.1.6 Macular Edema<br />

+1 888-702-9626 | www.marketdataforecast.com | contact@marketdataforecast.com


<strong>Ophthalmology</strong> therapeutics <strong>Market</strong><br />

5.2 By End User<br />

5.1.7 Allergic Conjunctivitis<br />

5.2.1 Hospitals<br />

5.2.2 Eye Clinics<br />

5.2.3 Diagnostic Centers<br />

5.2.4 Patients<br />

6. Geographical Analysis<br />

6.1 Introduction<br />

6.2 U.K<br />

6.3 Spain<br />

6.4 Germany<br />

6.5 Italy<br />

6.6 France<br />

7. Pipeline Product Analysis<br />

7.1 Overview<br />

7.2 Pipeline Development Landscape<br />

7.3 Molecular Targets in the Pipeline<br />

7.4 Clinical Trials<br />

7.4.1 Failure Rate by Stage of Development, Indication, Molecule Type<br />

and Molecular Target<br />

7.4.2 Clinical Trial Duration by Stage of Development, Indication,<br />

Molecule Type and Molecular Target<br />

7.4.3 Clinical Trial Size by Stage of Development, Indication, Molecule<br />

Type and Molecular Target<br />

8. Strategic Analysis<br />

8.1 PESTLE analysis<br />

8.1.1 Political<br />

+1 888-702-9626 | www.marketdataforecast.com | contact@marketdataforecast.com


<strong>Ophthalmology</strong> therapeutics <strong>Market</strong><br />

8.1.2 Economic<br />

8.1.3 Social<br />

8.1.4 Technological<br />

8.1.5 Legal<br />

8.1.6 Environmental<br />

8.2 Porter’s Five analysis<br />

8.2.1 Bargaining Power of Suppliers<br />

8.2.2 Bargaining Power of Consumers<br />

8.2.3 Threat of New Entrants<br />

8.2.4 Threat of Substitute Products and Services<br />

8.2.5 Competitive Rivalry within the Industry<br />

9. <strong>Market</strong> Leaders' Analysis<br />

9.1 Allergan, Inc.<br />

9.1.1 Overview<br />

9.1.2 Product Analysis<br />

9.1.3 Financial analysis<br />

9.1.4 Recent Developments<br />

9.1.5 SWOT analysis<br />

9.1.6 Analyst View<br />

9.2 Merck & Co Inc<br />

9.3 Pfizer<br />

9.4 Roche<br />

9.5 Novartis (Alcon)<br />

9.6 Valeant<br />

9.7 Regeneron<br />

9.8 Santen<br />

+1 888-702-9626 | www.marketdataforecast.com | contact@marketdataforecast.com


<strong>Ophthalmology</strong> therapeutics <strong>Market</strong><br />

9.9 Bayer<br />

9.10 Senju<br />

9.11 Lpath<br />

9.12 Eye Gate Pharmaceuticals<br />

10. Competitive Landscape<br />

10.1 <strong>Market</strong> share analysis<br />

10.2 Merger and Acquisition Analysis<br />

10.3 Agreements, collaborations and Joint Ventures<br />

10.4 New Product Launches<br />

11. <strong>Market</strong> Outlook & Investment Opportunities<br />

Appendix<br />

a) List of Tables<br />

b) List of Figures<br />

Check out other related reports in Healthcare<br />

Check out other related reports in Healthcare Segment<br />

Veterinary vaccines <strong>Market</strong>: http://www.marketdataforecast.com/market-reports/veterinaryvaccines-market-75/<br />

Companion Animal Healthcare <strong>Market</strong>: http://www.marketdataforecast.com/marketreports/global-companion-animal-health-care-market-1249/<br />

Anatomy Pathology <strong>Market</strong>: http://www.marketdataforecast.com/market-reports/anatomypathology-market-3337/<br />

Mycoplasma Testing <strong>Market</strong>: http://www.marketdataforecast.com/market-reports/mycoplasmatesting-market-3662/<br />

+1 888-702-9626 | www.marketdataforecast.com | contact@marketdataforecast.com


<strong>Ophthalmology</strong> therapeutics <strong>Market</strong><br />

SCOPE OF THE REPORT<br />

<br />

<br />

<br />

<br />

<br />

Regional and country-level analysis and forecasts of the study market; providing<br />

Insights on the major countries/regions in which this industry is blooming and to also<br />

identify the regions that are still untapped<br />

Segment-level analysis in terms of technology, component, and type along with<br />

market size forecasts and estimations to detect key areas of industry growth in detail<br />

Identification of key drivers, restraints, opportunities, and challenges (DROC) in the<br />

market and their impact on shifting market dynamics<br />

Study of the effect of exogenous and endogenous factors that affect the global<br />

market; which includes broadly demographic, economics, and political, among other<br />

macro-environmental factors presented in an extensive PESTLE Analysis<br />

Study the micro environment factors that determine the overall profitability of an<br />

Industry, using Porter’s five forces analysis for analyzing the level of competition<br />

and business strategy development<br />

+1 888-702-9626 | www.marketdataforecast.com | contact@marketdataforecast.com


<strong>Ophthalmology</strong> therapeutics <strong>Market</strong><br />

<br />

<br />

<br />

<br />

A comprehensive list of key market players along with their product portfolio,<br />

current strategic interests, key financial information, legal issues, SWOT analysis and<br />

analyst overview to study and sustain the market environment<br />

Competitive landscape analysis listing out the mergers, acquisitions, collaborations<br />

in the field along with new product launches, comparative financial studies and<br />

recent developments in the market by the major companies<br />

An executive summary, abridging the entire report in such a way that decisionmaking<br />

personnel can rapidly become acquainted with background information,<br />

concise analysis and main conclusions<br />

Expertly devised analyst overview along with Investment opportunities to provide<br />

both individuals and organizations a strong financial foothold in the market<br />

+1 888-702-9626 | www.marketdataforecast.com | contact@marketdataforecast.com


ABOUT US<br />

<strong>Market</strong> Data Forecast is a firm working in the areas of market<br />

research and business intelligence. We have rich experience in<br />

research across various business domains and we cater to the needs<br />

of both individual and corporate clients. Our research services assist<br />

clients in key business areas like business process improvement, key<br />

decision making and developing appropriate corporate strategy. We<br />

are truly committed to our clients and other stakeholders for<br />

providing customized research services of the highest quality.<br />

CONTACT INFORMATION<br />

We always look forward to working with new clients, pushing our<br />

boundaries and extending our reach beyond global horizons. Get in<br />

touch with us for further queries.<br />

Website: www.marketdataforecast.com<br />

E-Mail: contact@marketdataforecast.com<br />

Phone: +1 888-702-9626 (U.S Toll free),<br />

+91 7680952236 (Indian Office).<br />

FOR MORE INFORMATION<br />

+1 888-702-9626 | www.marketdataforecast.com | contact@marketdataforecast.com

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!